For instance, EGFR-mutant adenocarcinomas exhibit elevated Tregs and low effector T cell infiltration, while SCCs display robust but suppressed immune infiltrates due to extensive immune checkpoint upregulation[22,26,28-30,33,37,48,51,55]. The gene discussed is EGFR; the disease is adenocarcinoma.